ES2056843T3 - Amidas de acidos grasos inhibidoras de acil-coa: colesterol aciltransferasa. - Google Patents

Amidas de acidos grasos inhibidoras de acil-coa: colesterol aciltransferasa.

Info

Publication number
ES2056843T3
ES2056843T3 ES88102644T ES88102644T ES2056843T3 ES 2056843 T3 ES2056843 T3 ES 2056843T3 ES 88102644 T ES88102644 T ES 88102644T ES 88102644 T ES88102644 T ES 88102644T ES 2056843 T3 ES2056843 T3 ES 2056843T3
Authority
ES
Spain
Prior art keywords
cholesterol
aciltransferasa
acil
fatty acid
acid amides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88102644T
Other languages
English (en)
Inventor
Milton Louis Hoefle
Ann Holmes
Bruce David Roth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of ES2056843T3 publication Critical patent/ES2056843T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/07—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/09—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

CIERTAS AMIDAS SUSTITUIDAS DE ACIDOS GRASOS SATURADOS SON POTENTES INHIBIDORES DE LA ENZIMA ACIL-COA:COLESTEROL ANTITRANSFERASA Y SE EMPLEAN COMO AGENTES PARA INHIBIR LA ABSORCION INTESTINAL DEL COLESTEROL.
ES88102644T 1987-02-24 1988-02-23 Amidas de acidos grasos inhibidoras de acil-coa: colesterol aciltransferasa. Expired - Lifetime ES2056843T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/017,960 US4716175A (en) 1987-02-24 1987-02-24 Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase

Publications (1)

Publication Number Publication Date
ES2056843T3 true ES2056843T3 (es) 1994-10-16

Family

ID=21785503

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88102644T Expired - Lifetime ES2056843T3 (es) 1987-02-24 1988-02-23 Amidas de acidos grasos inhibidoras de acil-coa: colesterol aciltransferasa.

Country Status (17)

Country Link
US (1) US4716175A (es)
EP (1) EP0283742B1 (es)
JP (1) JPH07121895B2 (es)
KR (1) KR880009933A (es)
AT (1) ATE89814T1 (es)
CA (1) CA1336913C (es)
DE (1) DE3881249T2 (es)
DK (1) DK165406C (es)
ES (1) ES2056843T3 (es)
FI (1) FI89593C (es)
HK (1) HK148195A (es)
IE (1) IE59998B1 (es)
MX (1) MX9203139A (es)
NO (1) NO174043C (es)
NZ (1) NZ223410A (es)
PT (1) PT86811B (es)
ZA (1) ZA88604B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8827152D0 (en) * 1988-11-21 1988-12-29 Wellcome Found Anti-atherosclerotic diaryl compounds
US5290814A (en) * 1988-11-21 1994-03-01 Burroughs Wellcome Co. Anti-atherosclerotic diaryl compounds
US5153226A (en) * 1989-08-31 1992-10-06 Warner-Lambert Company Acat inhibitors for treating hypocholesterolemia
MX22406A (es) * 1989-09-15 1994-01-31 Pfizer Nuevos derivados de n-aril y n-heteroarilamidas y urea como inhibidores de acil coenzima a: acil transferasa del colesterol (acat).
AU6659090A (en) * 1989-11-16 1991-06-13 Warner-Lambert Company Acat inhibitors
WO1991015464A1 (en) * 1990-04-11 1991-10-17 Warner-Lambert Company Amide ester acat inhibitors
US5149709A (en) * 1990-07-03 1992-09-22 Schering Corporation Inhibitors of acyl-coenzyme A: cholesterol acyl transferase
CA2087423A1 (en) * 1990-07-25 1992-01-26 Tatsuki Shiota Benzopyran derivative, process for producing the same and pharmaceutical composition containing the same
US5668136A (en) * 1990-09-25 1997-09-16 Eisai Co., Ltd. Trisubstituted benzene derivatives, composition and methods of treatment
DE69119434T2 (de) * 1990-11-26 1996-09-12 Taisho Pharmaceutical Co Ltd Anilidderivat
FR2673625B1 (fr) * 1991-03-08 1993-05-07 Adir Nouveaux derives d'acylaminophenol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5420164A (en) * 1991-04-04 1995-05-30 Yoshitomi Pharmaceutical Industries, Ltd. Cycloalkylurea compounds
US5416212A (en) * 1991-12-25 1995-05-16 Taisho Pharmaceutical Co., Ltd. Anilide derivatives
US6001860A (en) * 1992-05-28 1999-12-14 Pfizer Inc. N-aryl and N-heteroarylurea derivatives as inhibitors of acyl coenzyme A: Cholesterol acyl transferase (ACAT)
US5462958A (en) * 1992-07-20 1995-10-31 Eisai Co., Ltd. Benzene derivatives and method of treating arteriosclerosis with benzene derivatives
US5321031A (en) * 1992-09-23 1994-06-14 Schering Corporation 1,2-disubstituted ethyl amides as inhibitors of ACAT
CA2107196A1 (en) * 1992-09-29 1994-03-30 Mitsubishi Chemical Corporation Carboxamide derivatives
US5565472A (en) * 1992-12-21 1996-10-15 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
US5534529A (en) * 1993-06-30 1996-07-09 Sankyo Company, Limited Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
NZ264063A (en) * 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
US5596001A (en) * 1993-10-25 1997-01-21 Pfizer Inc. 4-aryl-3-(heteroarylureido)quinoline derivatves
IT1265209B1 (it) * 1993-11-22 1996-10-31 Pierrel Spa Difenilimidazoli utili nel trattamento di dislipidemia, arteriosclerosi e malattie coronariche procedimento per la loro
US6133326A (en) 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
KR960031425A (ko) * 1995-02-08 1996-09-17 시미주 마사미 다중불포화된 지방산 잔기를 갖는 아닐린 유도체 및 그의 용도
HUP0301010A3 (en) * 2000-02-02 2005-03-29 Warner Lambert Co Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders and pharmaceutical compositions containing them
IL146531A0 (en) * 2000-03-16 2002-07-25 Neurogen Corp 5-substituted arylpyrimidines
US20040072903A1 (en) * 2001-05-08 2004-04-15 Auerbach Bruce Jeffrey Carboxyalkylether-acat inhibitors combinations
EP1281399A3 (en) * 2001-08-01 2004-02-11 Warner-Lambert Company Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production
SI1725234T1 (sl) 2004-03-05 2013-04-30 The Trustees Of The University Of Pennsylvania Postopki zdravljenja nepravilnosti ali bolezni povezanih s hiperlipidemijo in hiperholesterolemijo z minimiziranjem stranskih uäśinkov
TW200831497A (en) * 2006-10-12 2008-08-01 Epix Delaware Inc Carboxamide compounds and their use
JP2011506466A (ja) 2007-12-11 2011-03-03 株式会社サイトパスファインダー カルボキサミド化合物ならびにケモカイン受容体アゴニストとしてのそれらの使用
EP3025727A1 (en) 2008-10-02 2016-06-01 The J. David Gladstone Institutes Methods of treating liver disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL238088A (es) * 1958-04-14
BE620639A (es) * 1961-07-25
SE353319B (es) * 1964-08-15 1973-01-29 Sumitomo Chemical Co
DE1618959C3 (de) * 1967-10-04 1978-12-14 Sumitomo Chemical Co., Ltd., Osaka (Japan) Fettsäureamide und Verfahren zu ihrer Herstellung
DE2830351A1 (de) * 1978-07-11 1980-01-24 Consortium Elektrochem Ind Acylanilide
GR69291B (es) * 1979-06-25 1982-05-13 May & Baker Ltd
GB2080808B (en) * 1980-01-25 1984-01-04 Reanal Finomvegyszergyar Process for the preparation of n-aryl-n-(mono- or disubstituted)-urea derivatives
NZ216253A (en) * 1985-05-27 1989-07-27 Mitsui Toatsu Chemicals N-(3-chloro-4-isopropylphenyl)-carboxamide derivatives and herbicidal compositions
MA20552A1 (fr) * 1985-10-11 1986-07-01 Pan Medica Sa Alkylacarboxamides de pyridylalkylamines,leurs preparations et leurs utilisations

Also Published As

Publication number Publication date
NO174043C (no) 1994-03-09
US4716175A (en) 1987-12-29
JPH07121895B2 (ja) 1995-12-25
PT86811A (pt) 1988-03-01
DK165406C (da) 1993-04-13
US4716175B1 (es) 1993-06-22
IE880204L (en) 1988-08-24
MX9203139A (es) 1992-07-01
FI89593C (fi) 1993-10-25
DK165406B (da) 1992-11-23
FI89593B (fi) 1993-07-15
ZA88604B (en) 1989-09-27
NO880774D0 (no) 1988-02-23
KR880009933A (ko) 1988-10-05
NO880774L (no) 1988-08-25
DE3881249T2 (de) 1993-09-16
AU1135488A (en) 1988-08-25
JPS63253060A (ja) 1988-10-20
CA1336913C (en) 1995-09-05
EP0283742A3 (en) 1989-07-26
ATE89814T1 (de) 1993-06-15
NZ223410A (en) 1989-11-28
DE3881249D1 (en) 1993-07-01
NO174043B (no) 1993-11-29
EP0283742A2 (en) 1988-09-28
FI880796A0 (fi) 1988-02-19
EP0283742B1 (en) 1993-05-26
IE59998B1 (en) 1994-05-18
HK148195A (en) 1995-09-22
DK94188D0 (da) 1988-02-23
DK94188A (da) 1988-08-25
FI880796A (fi) 1988-08-25
PT86811B (pt) 1992-05-29
AU610558B2 (en) 1991-05-23

Similar Documents

Publication Publication Date Title
US4716175B1 (es)
FI914905A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten merkaptoasetyyliamidopyrrolo- ja -pyridobentsatsepiinijohdannaisten valmistamiseksi
GR3001523T3 (en) Substituted pyrimidine amides of oleic or linoleic acid as inhibitors of acyl-coa cholesterol acyltransferase
DE3587230T2 (de) Enzymatisches verfahren.
NO930525D0 (no) Framgangsmaate for utvikling av umettede fettsyrer
ES544466A0 (es) Procedimiento para la fabricacion de esteres de triterpenilode acidos organicos
ES2025122B3 (es) Procedimiento para obtencion de esteres de acidos alquencarboxilicos.
DE58907973D1 (de) Verfahren zur Desodorierung von Fettsäureestergemiscchen.
FR2580667B1 (fr) Procede de preparation enzymatique de l-amino acides renfermant du soufre
PT88436A (pt) Process for the preparation of modified plasminogen activators
EP0276392A3 (en) Process for the isolation of l-amino acids
FR2611201B1 (fr) Intermediaires de tetrazole et procede de preparation de derives antihypercholesterolemiques du tetrazole
AU610558C (en) Saturated fatty acid amides as inhibitors of acyl-coa: cholesterol acyltransferase
BR8804533A (pt) Processo para preparacao de esteres de acidos 1-aril-pirazol-3-carboxilicos
FR2589151B1 (fr) Procede de preparation d'esters du diethyleneglycol
RO78151A2 (ro) Procedeu de biosinteza industriala a l-lizinei furajere
FI103114B1 (fi) Menetelmä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten valmistamiseksi
ES1002901Y (es) Mueble-rascador para ciertos tipos de loteria
BR6500655U (pt) Apresentacao de produtos diversos
BG47314A1 (en) Device for fastening of bearings during their testing process
ES544776A0 (es) Procedimiento para la obtencion de esteres alquilicos de a- cidos bencimidazolcarbamicos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 283742

Country of ref document: ES